FDA ARGOS Team – DoD USAMRIID Collaboration on Biothreat Detection
The Ebola outbreak in West Africa in 2014 used advanced infectious disease (ID) detection technology based on next generation sequencing (NGS) to determine index case and potential novel microbes. Current ID-NGS technology is still evolving and typically involves complex laboratory and bioinformatics workflows. The use of NGS provides a biased-free, detailed view of infectious microorganisms that promises to enable faster detection, traceback, and selection of therapeutics without prior knowledge of disease cause. To reach these objectives, ID NGS computational workflows must be independently evaluated and validated.
[read more at the full blog]